Active Implants LLC

MEMPHIS, TN · Founded 2013 · Medtech · Private

Implantable neurostimulation device for spinal cord injury treatment

Claim this profile

Follows are private to you and power your alerts

Updated · nusurfaceimplant.com

Sector
Medtech
Headquarters
MEMPHIS, TN
Founded
2013
Latest Form D
$5.5M, Feb 2022
Total capital
$105M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$105M
6 Form D · last Feb 2022
57 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
13
7 pending · first 2016
Rank in peer group#170 of 1112

Capital timeline

20132015201720192021FEDERAL ↑EQUITY ↓Cumulative $105M2nd Form D$48.7M3rd Form D$10M5th Form D$36.8M6th Form D$5.5M
20132015201720192021FEDERAL ↑EQUITY ↓Cumulative $105M2nd Form D$48.7M5th Form D$36.8M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$5.5M
  • Private capital raisedForm D · SEC · 5th filing$36.8M
  • Private capital raisedForm D · SEC · 4th filing$3.3M
  • Private capital raisedForm D · SEC · 3rd filing$10M
  • Private capital raisedForm D · SEC · 2nd filing$48.7M
  • Private capital raisedForm D · SEC · 1st filing$600K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#170 · top 15%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Adam T. KlyceExecutive OfficerNamed in SEC Form D filings
  • Amiram SteinbergDirectorNamed in SEC Form D filings
  • Charles W. FedericoDirectorNamed in SEC Form D filings
  • Charles MartinDirectorNamed in SEC Form D filings
  • Corporation Active ImplantsPromoterNamed in SEC Form D filings
  • Dennis LongExecutive OfficerNamed in SEC Form D filings
Show all 31 people
  • Erik W. HarrisExecutive OfficerNamed in SEC Form D filings
  • Gary D. HenleyDirectorNamed in SEC Form D filings
  • Haynes T. MorrisDirectorNamed in SEC Form D filings
  • Henry Michael KlyceExecutive Officer, DirectorNamed in SEC Form D filings
  • Jack BlairExecutive Officer, DirectorNamed in SEC Form D filings
  • James D. LackieDirectorNamed in SEC Form D filings
  • J Michael KeenanExecutive OfficerNamed in SEC Form D filings
  • J. Michael KeenanExecutive OfficerNamed in SEC Form D filings
  • Larry KlugeExecutive OfficerNamed in SEC Form D filings
  • Lawrence KlugeExecutive OfficerNamed in SEC Form D filings
  • Lex GiltaijExecutive OfficerNamed in SEC Form D filings
  • Michael KeenanExecutive OfficerNamed in SEC Form D filings
  • Michael LewisExecutive OfficerNamed in SEC Form D filings
  • Michael MainelliDirectorNamed in SEC Form D filings
  • Noam WeissbergExecutive OfficerNamed in SEC Form D filings
  • Richard TreharneExecutive OfficerNamed in SEC Form D filings
  • Ryan W. BelaneyExecutive OfficerNamed in SEC Form D filings
  • Spence T. Wilson, Jr.DirectorNamed in SEC Form D filings
  • Stephen BradshawExecutive Officer, DirectorNamed in SEC Form D filings
  • Ted DavisExecutive Officer, DirectorNamed in SEC Form D filings
  • Thomas BufordExecutive OfficerNamed in SEC Form D filings
  • Tim W. RinksExecutive OfficerNamed in SEC Form D filings
  • Troy DrewryExecutive OfficerNamed in SEC Form D filings
  • William T. Mays, Jr.DirectorNamed in SEC Form D filings
  • William W. RobinsonDirectorNamed in SEC Form D filings

What it has protected

USPTO · 13 granted of 20
Show all 20 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .